Upgrading facilities to study infectious diseases and develop treatments
Modernization of high and maximum containment research facilities at the National Emerging Infectious Diseases Laboratories (NEIDL) to meet current and future national research priorities
This study is working to upgrade the labs at Boston University that study dangerous germs, like COVID-19, so that scientists can create better vaccines and treatments to help keep everyone safe during outbreaks and future pandemics.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Boston University Medical Campus NIH-funded |
| Lab location | 1 site (Boston, United States) |
| Project ID | NIH-11015517 on NIH RePORTER |
What this research studies
This research focuses on modernizing the National Emerging Infectious Diseases Laboratories (NEIDL) at Boston University to enhance the study of new and reemerging infectious pathogens, including the COVID-19 virus. By improving the infrastructure and operational efficiency of high and maximum containment labs, the project aims to facilitate the development of vaccines, therapeutics, and diagnostics. Patients can benefit from this research as it aims to address urgent public health needs and improve responses to future pandemics. The approach includes upgrading containment measures and enhancing research capabilities to allow for more effective studies on various pathogens.
Who could benefit from this research
Good fit: Ideal candidates for participation or benefit from this research include individuals affected by or at risk for infectious diseases, particularly those related to emerging pathogens like SARS-CoV-2.
Not a fit: Patients with chronic conditions unrelated to infectious diseases may not receive direct benefits from this research.
Why it matters
Potential benefit: If successful, this research could lead to faster development of effective vaccines and treatments for infectious diseases, ultimately improving patient outcomes during pandemics.
How similar studies have performed: Other research initiatives focused on upgrading containment facilities have shown success in enhancing the study of infectious diseases, indicating that this approach is both tested and necessary.
Where this research is happening
Boston, United States
- Boston University Medical Campus — Boston, United States (Active)
Researchers
- Principal investigator: Sullivan, Nancy Jean — Boston University Medical Campus
- Study coordinator: Sullivan, Nancy Jean
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.